Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
暂无分享，去创建一个
C. Pisano | V. Salutari | V. Carbone | V. Tuninetti | V. Forestieri | M. Ducceschi | M. Bellero | G. Scandurra | M. C. Petrella | Serafina Mammoliti | Sandro Pignata | Elisa Virano | Andrea Ricotti | Giacinto Turitto | Monica Rizzetto | Grazia Artioli | Raffaella Cioffi | Lucia Borsotti | Chiara Rognone | Gabriella Ferrandina | Mara Mantiero | Carmen Azzolina | Eleonora Geninatti | Giorgio Valabrega